Prototype of information system for adverse drug reaction monitoring in hospitals
Keywords:
Adverse drug reaction monitoring, Digital-based information systems, PrototypeAbstract
Adverse Drug Reaction Monitoring (ADRM) is one of the responsibilities of pharmacists in hospitals. However, practitioners experience problems documenting monitoring results due to the limited support for digital-based information systems. Our article presents a prototype information system for pharmacists to store data on the results of ADRM activities. The prototype includes a flowchart and user interface design of the system's operations. The preparation of flowcharts uses the draw.io application, which is confirmed by the design of the user interface developed with the Microsoft PowerPoint application. Our prototype shows a series of menus beginning with user login, a three-step ADRM data input process, and two steps for displaying patient data. Furthermore, the development of prototypes in the form of software applications will present a digital-based transformation of the role of pharmacists, which certainly optimizes performance in ADRM documentation. The proposed data analysis approach, as well as system performance, has been tested. The results show that this system can potentially increase the spontaneous reporting rate of suspected adverse drug reactions.
References
[1] BPOM RI, Pedoman Monitoring Efek Samping Obat (MESO) Bagi Tenaga Kesehatan. Jakarta: Direktorat Pengawasan Distribusi Produk Terapetik dan PKRT Badan POM RI, 2012.
[2] ‘Panduan Monitoring Efek Samping Obat RSUD Dr. Saiful Anwar Malang’. Rumah Sakit Muji Rahayu Surabaya, 2017.
[3] S. B. Santoso, H. Lutfiyati, U. H. Afifi, and S. Ratnafuri, ‘Quality of Life Profile Based on Controlled First-line Antiretroviral Treatment in Patients with HIV Infection’, in Proceedings of the 2nd Borobudur International Symposium on Humanities and Social Sciences, BIS-HSS 2020, 18 November 2020, Magelang, Central Java, Indonesia, Magelang, Indonesia, Sep. 2021. doi: 10.4108/eai.18-11-2020.2311628.
[4] S. B. Santoso, H. Lutfiyati, R. I. Prasidha, S. Ratnafuri, and K. A. Azzahra, ‘What Do Patients with Hiv-Infection Perceive and Know Regarding to Antiretrovirals? An Exploration Among Participants Undergoing Controlled-Therapy’, Technology Report Kansai University, vol. 62, no. 04, p. 8, Apr. 2020.
[5] Peraturan Menteri Kesehatan Nomor 72 Tahun 2016 Standar Pelayanan Kefarmasian di Rumah Sakit. 2016.
[6] H. Lutfiyati, P. Pribadi, and S. B. Santoso, ‘Kesiapan Apoteker dalam Memberikan Layanan Medication Therapy Management’, CERATA Jurnal Ilmu Farmasi, vol. 10, no. 1, p. 5, Jul. 2019.
[7] H. Lutfiyati, B. Mintarsih, S. B. Santoso, and D. K. Dewi, ‘Evaluasi Sumber Daya Apoteker Berdasarkan Standar Pelayanan Kefarmasian Terkait Sumber Daya Manusia di Apotek Kabupaten Temanggung’, in Challenges & Opportunities of Pharmapreneurship 4.0 in Universal Health Coverage (UHC) Era, Surakarta, Indonesia, 2020.
[8] D. Pandiangan, ‘Kajian Kinerja Kefarmasian Di RUMAH SAKIT Dr. Ferdinand Lumbantobing Sibolga Tahun 2020’, Jurnal Inovasi Kesehatan Masyarakat, vol. 2, no. 2, 2021.
[9] H. Tika, ‘Evaluasi Tingkat Pengetahuan, Sikap dan Praktik Apoteker Rumah Sakit Tentang Pelaporan Monitoring Efek Samping Obat Di Kota Bengkulu’. Universitas Andalas, 2021.
[10] N. U. Salamah, N. R. Majid, A. F. Makarim, P. Pribadi, and S. B. Santoso, ‘Website-based Scientific Traditional Medicine Information Prototype’, in Peran Perguruan Tinggi dalam Menjaga Stabilitas Nasional pasca Pandemi Covid-19, Universitas Muhammadiyah Gombong, Mar. 2022.
[11] P. D. Savita, D. Miftahuda, W. A. Safi, and S. B. Santoso, ‘Online Home Pharmacy Care Prototype’, in Peran Perguruan Tinggi dalam Menjaga Stabilitas Nasional pasca Pandemi Covid-19, Universitas Muhammadiyah Gombong, Mar. 2022, p. 8.
[12] S. L. Anggitha, N. Rahayu, P. Pribadi, and S. B. Santoso, ‘Telegram-Bot Applications in Drug Information Services and Pharmaceutical Counseling’, in Peran Perguruan Tinggi dalam Menjaga Stabilitas Nasional pasca Pandemi Covid-19, Universitas Muhammadiyah Gombong, Mar. 2022, p. 8.
[13] H. Hayurani and F. D. Hartanti, ‘Sistem Monitoring Dan Controlling Pasien Tuberkulosis (Tb)’, Jurnal Teknologi Informasi YARSI, vol. 3, no. 1, pp. 8–17, 2016.
[14] E. Yulianti, A. A. K. O. Sudana, N. Made, and I. Marini, ‘Perancangan Sistem Informasi Manajemen Rumah Sakit Modul Farmasi’, Perancangan Sistem Informasi Manajemen Rumah Sakit Modul Farmasi, vol. 6, no. 2, pp. 96–107, 2015, doi: 10.24843/LKJITI.6.2.16704.
[15] R. Agussalim, A. Adnan, and M. Niswar, ‘Monitoring Cairan Infus Berdasarkan Indikator Kondisi Dan Laju Cairan Infus Menggunakan Jaringan Wifi’, ILKOM Jurnal Ilmiah, vol. 8, no. 3, pp. 145–152, 2016, doi: 10.33096/ilkom.v8i3.69.145-152.
[16] S. B. Santoso, M. H. N. Majid, A. A. Suryaningtyas, R. Faizah, and I. M. P. Wibowo, ‘Interaction Exchange in Dispensaries: An Observation on the Chronic Disease Management Program’, in Proceedings of the 2nd Borobudur International Symposium on Humanities and Social Sciences, BIS-HSS 2020, 18 November 2020, Magelang, Central Java, Indonesia, Magelang, Indonesia, Sep. 2021. doi: 10.4108/eai.18-11-2020.2311623.
[17] A. A. Suryaningtyas, A. N. Vianto, M. B. Octaviano, and S. B. Santoso, ‘The Pharmacist-Patient Communication Model in the Chronic Disease Management Program’, in Proceedings of the 2nd Borobudur International Symposium on Humanities and Social Sciences, BIS-HSS 2020, 18 November 2020, Magelang, Central Java, Indonesia, Magelang, Indonesia, Sep. 2021. doi: 10.4108/eai.18-11-2020.2311746.
[18] A. R. Pratama, D. A. Hutagalung, W. Siregar, and H. Sihombing, ‘Monitoring patient health based on medical records using fuzzy logic method’, SinkrOn, vol. 3, no. 2, p. 20, 2019, doi: 10.33395/sinkron.v3i2.10014.
[19] J. Fossouo Tagne, R. A. Yakob, T. H. Dang, R. Mcdonald, and N. Wickramasinghe, ‘Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review’, JMIR Public Health Surveill, vol. 9, p. e40080, Jan. 2023, doi: 10.2196/40080.
[20] C. Foreman, W. B. Smith, G. E. Caughey, and S. Shakib, ‘Categorization of Adverse Drug Reactions in Electronic Health Records’, Pharmacol Res Perspect, vol. 8, no. 2, Apr. 2020, doi: 10.1002/prp2.550.
[21] S. B. Santoso, P. U. Chabibah, and P. Pribadi, ‘Resiko Hepatotoksik Populasi Indonesia Akibat Polimorfisme Enzim NAT2 dan CYP2E1 dalam Metabolisme Isoniazid’, UJAS, vol. 1, no. 1, pp. 9–16, Apr. 2021, doi: 10.53017/ujas.11.
[22] D. Brandariz-NÃoÃ, ‘Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization’, Farmacia Hospitalaria, 2023.
[23] S. Wardani, S. H. P. Nugroho, and S. B. Santoso, ‘An evaluation of Dehydration Assessment and Zinc Administration in Children with Acute Diarrhea in Hospitals’, in Proceedings of the 2nd Borobudur International Symposium on Humanities and Social Sciences, BIS-HSS 2020, 18 November 2020, Magelang, Central Java, Indonesia, Magelang, Indonesia, 2021. doi: 10.4108/eai.18-11-2020.2311762.
[24] R. Braund, C. K. Lawrence, L. Baum, B. Kessler, M. Vassart, and C. Coulter, ‘Quality of Electronic Records Documenting Adverse Drug Reactions Within a Hospital Setting: Identi Cation of Discrepancies and Information Completeness’, vol. 132, no. 1488, 2019.
[25] Kementerian Kesehatan Republik Indonesia, Peraturan Menteri Kesehatan Republik Indonesia Nomor 46 Tahun 2017 Tentang Strategi E-Kesehatan Nasional. 2017.
[26] Peraturan Pemerintah Republik Indonesia Nomor 46 Tahun 2014 Tentang Sistem Informasi Kesehatan. 2014.
[27] A. Wasylewicz et al., ‘Identifying Adverse Drug Reactions from Free‐Text Electronic Hospital Health Record Notes’, Brit J Clinical Pharma, vol. 88, no. 3, pp. 1235–1245, Mar. 2022, doi: 10.1111/bcp.15068.
[28] S. Karimi, C. Wang, A. Metke-Jimenez, R. Gaire, and C. Paris, ‘Text and Data Mining Techniques in Adverse Drug Reaction Detection’, ACM Comput. Surv., vol. 47, no. 4, pp. 1–39, Jul. 2015, doi: 10.1145/2719920.
[29] P. Annu, ‘ADR Monitoring: An Essential Need for Better Health Care and Safety’, PharmaTutor, vol. 4, no. 8, pp. 13–16, 2016, doi: 2347 - 7881.
[30] K. Sienkiewicz, M. Burzyńska, I. Rydlewska-Liszkowska, J. Sienkiewicz, and E. Gaszyńska, ‘The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process’, IJERPH, vol. 19, no. 1, p. 413, Dec. 2021, doi: 10.3390/ijerph19010413.
[31] R. A. Raschke et al., ‘A Computer Alert System to Prevent Injury From Adverse Drug Events: Development and Evaluation in a Community Teaching Hospital’, JAMA, vol. 280, no. 15, p. 1317, Oct. 1998, doi: 10.1001/jama.280.15.1317.
Downloads
Published
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.